PT953630E - Produtos de trans-esterificacao de oleo de milho e glicerol e seu uso em composicoes farmaceuticas - Google Patents

Produtos de trans-esterificacao de oleo de milho e glicerol e seu uso em composicoes farmaceuticas

Info

Publication number
PT953630E
PT953630E PT99106122T PT99106122T PT953630E PT 953630 E PT953630 E PT 953630E PT 99106122 T PT99106122 T PT 99106122T PT 99106122 T PT99106122 T PT 99106122T PT 953630 E PT953630 E PT 953630E
Authority
PT
Portugal
Prior art keywords
trans
glycerol
pharmaceutical compositions
esterification products
wood oil
Prior art date
Application number
PT99106122T
Other languages
English (en)
Inventor
Armin Meinzer
Jacky Vonderscher
Birgit Hauer
Ulrich Posanski
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10697415&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT953630(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PT953630E publication Critical patent/PT953630E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11C—FATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
    • C11C3/00—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom
    • C11C3/04—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by esterification of fats or fatty oils
    • C11C3/06—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by esterification of fats or fatty oils with glycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nanotechnology (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medical Informatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Transplantation (AREA)
  • Communicable Diseases (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fats And Perfumes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Confectionery (AREA)
PT99106122T 1991-06-27 1992-06-23 Produtos de trans-esterificacao de oleo de milho e glicerol e seu uso em composicoes farmaceuticas PT953630E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919113872A GB9113872D0 (en) 1991-06-27 1991-06-27 Improvements in or relating to organic compounds

Publications (1)

Publication Number Publication Date
PT953630E true PT953630E (pt) 2004-11-30

Family

ID=10697415

Family Applications (2)

Application Number Title Priority Date Filing Date
PT92810479T PT539319E (pt) 1991-06-27 1992-06-23 Composicoes farmaceuticas de ciclosporina
PT99106122T PT953630E (pt) 1991-06-27 1992-06-23 Produtos de trans-esterificacao de oleo de milho e glicerol e seu uso em composicoes farmaceuticas

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PT92810479T PT539319E (pt) 1991-06-27 1992-06-23 Composicoes farmaceuticas de ciclosporina

Country Status (38)

Country Link
EP (2) EP0539319B1 (pt)
JP (2) JP2653958B2 (pt)
KR (3) KR0131064B1 (pt)
CN (1) CN1077798C (pt)
AT (1) AT403436B (pt)
AU (1) AU659460B2 (pt)
CA (2) CA2175842C (pt)
CH (2) CH685764A5 (pt)
CY (1) CY1906A (pt)
CZ (1) CZ281790B6 (pt)
DE (3) DE4219526C2 (pt)
DK (2) DK0539319T3 (pt)
EE (1) EE03108B1 (pt)
ES (2) ES2142818T3 (pt)
FI (2) FI109454B (pt)
FR (2) FR2678169B1 (pt)
GB (2) GB9113872D0 (pt)
GR (1) GR3032366T3 (pt)
HK (2) HK57196A (pt)
HU (1) HU216792B (pt)
IE (1) IE73662B1 (pt)
IL (3) IL118546A (pt)
IT (1) IT1254401B (pt)
LU (1) LU88138A1 (pt)
MX (1) MX9203236A (pt)
MY (1) MY109512A (pt)
NO (2) NO303964B1 (pt)
NZ (1) NZ243309A (pt)
PH (1) PH30337A (pt)
PT (2) PT539319E (pt)
RO (2) RO111021B1 (pt)
RU (1) RU2143919C1 (pt)
SA (1) SA92130213B1 (pt)
SK (1) SK278759B6 (pt)
TW (1) TW267943B (pt)
UA (1) UA35559C2 (pt)
UY (1) UY23864A1 (pt)
ZA (1) ZA924719B (pt)

Families Citing this family (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9113872D0 (en) * 1991-06-27 1991-08-14 Sandoz Ag Improvements in or relating to organic compounds
PT589843E (pt) 1992-09-25 2002-04-29 Novartis Ag Composicoes farmaceuticas contendo ciclosporinas
NZ247516A (en) * 1993-04-28 1995-02-24 Bernard Charles Sherman Water dispersible pharmaceutical compositions comprising drug dissolved in solvent system comprising at least one alcohol and at least one surfactant
CH686761A5 (de) * 1993-05-27 1996-06-28 Sandoz Ag Galenische Formulierungen.
AT408520B (de) * 1993-05-27 2001-12-27 Novartis Erfind Verwalt Gmbh Galenische formulierungen
GB2278780B (en) * 1993-05-27 1998-10-14 Sandoz Ltd Macrolide formulations
DE4322826A1 (de) * 1993-07-08 1995-01-12 Galenik Labor Freiburg Gmbh Pharmazeutisches Präparat
ATE398448T1 (de) * 1993-09-28 2008-07-15 Scherer Gmbh R P Herstellung von weichgelatinekapseln
DE4340781C3 (de) * 1993-11-30 2000-01-27 Novartis Ag Cyclosporin enthaltende flüssige Zubereitungen und Verfahren zu ihrer Herstellung
WO1995022343A1 (en) * 1994-02-17 1995-08-24 Shiseido Company, Ltd. Cyclosporin-containing emulsion composition
US5891846A (en) * 1994-02-17 1999-04-06 Shiseido Company, Ltd. Cyclosporin-containing emulsion composition
NZ270145A (en) * 1994-03-01 1996-08-27 Lilly Co Eli Non-aqueous pharmaceutical formulation for oral administration comprising water-insoluble active agent, fatty acid solubilising agent, an oil and a surface active agent
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
EP0679712B1 (en) * 1994-03-31 1999-06-23 Loders Croklaan B.V. Low safa oils
GB2308545B (en) * 1994-10-26 1999-06-02 Novartis Ag Pharmaceutical microemulsion preconcentrates
IL129547A (en) 1994-10-26 2001-01-11 Novartis Ag Pharmaceutical compositions comprising a macrolide and an acid
SK164796A3 (en) 1994-11-03 1997-06-04 Dresden Arzneimittel Novel cyclosporine preparation forms for oral administration of and process for producing them
HU215966B (hu) * 1994-11-21 1999-07-28 BIOGAL Gyógyszergyár Rt. Orálisan alkalmazható, ciklosporint tartalmazó, összetett emulzió-előkoncentrátum
US7048906B2 (en) 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
US6861053B1 (en) 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
WO1996036330A2 (en) * 1995-05-17 1996-11-21 Cedars-Sinai Medical Center Compositions containing fatty acids for improving digestion and absorption in the small intestine
JPH11505258A (ja) * 1995-05-17 1999-05-18 セダーシナイ メディカル センター 小腸における消化および吸収を改善させる脂肪酸を含む組成物
US6008228A (en) * 1995-06-06 1999-12-28 Hoffman-La Roche Inc. Pharmaceutical compositions containing proteinase inhibitors
US6696413B2 (en) * 1995-06-16 2004-02-24 Hexal Ag Pharmaceutical preparation with cyclosporin A
SE504582C2 (sv) * 1995-07-06 1997-03-10 Gs Dev Ab Cyklosporinkomposition baserad på en L2-fas
DE19544507B4 (de) * 1995-11-29 2007-11-15 Novartis Ag Cyclosporin enthaltende Präparate
US5858401A (en) * 1996-01-22 1999-01-12 Sidmak Laboratories, Inc. Pharmaceutical composition for cyclosporines
CN1104258C (zh) * 1996-05-29 2003-04-02 周德和 用于环孢霉素a的赋形剂
US5958876A (en) * 1996-06-19 1999-09-28 Novartis Ag Cyclosporin-containing pharmaceutical compositions
ATE392891T1 (de) * 1996-06-19 2008-05-15 Novartis Pharma Gmbh Cyclosporin enthaltende präparate
KR980008239A (ko) * 1996-07-26 1998-04-30 김충환 사이클로스포린-함유 약학적 조성물
FR2752732B1 (fr) * 1996-08-28 1998-11-20 Pf Medicament Forme galenique a liberation prolongee de milnacipran
ZA9711732B (en) 1996-12-31 1998-12-28 Quadrant Holdings Cambridge Methods and compositions for improvement bioavailability of bioactive agents for mucosal delivery
US6306434B1 (en) * 1997-02-12 2001-10-23 Chong Kun Dang Corp. Pharmaceutical composition comprising cyclosporin solid-state microemulsion
NZ337316A (en) * 1997-03-12 2001-06-29 Abbott Lab Hydrophilic binary systems comprising cyclosporine, hydrophilic phase and a surfactant for the administration of cyclosporine
AR012627A1 (es) 1997-04-29 2000-11-08 Sherman Bernard Charles Pre-concentrado de emulsion que comprende una ciclosporina y monoglicerido acetilado
NZ314702A (en) * 1997-04-29 1998-07-28 Bernard Charles Sherman Pharmaceutical composition comprising a cyclosporin in a solvent system of acetylated monoglycerides and a surfactant and optionally a hydrophilic solvent
GB2326337A (en) * 1997-06-20 1998-12-23 Phares Pharma Holland Homogeneous lipid compositions for drug delivery
HU228923B1 (en) 1997-07-29 2013-06-28 Upjohn Co Pharmaceutical composition for acidic lipophilic compounds in a form of a self-emulsifying formulation
ATE265847T1 (de) * 1997-07-29 2004-05-15 Upjohn Co Selbstemulgierbare formulierung enthaltend lipophile verbindungen
PL192080B1 (pl) * 1997-07-29 2006-08-31 Upjohn Co Kompozycja farmaceutyczna zawierająca związek piranonowy
US20030220234A1 (en) 1998-11-02 2003-11-27 Selvaraj Naicker Deuterated cyclosporine analogs and their use as immunodulating agents
US6673768B1 (en) 1997-10-16 2004-01-06 Board Of Regents, The University Of Texas System Transgenic animal models for cardiac hypertrophy and methods of use thereof (treating)
WO1999029316A1 (en) 1997-12-10 1999-06-17 Severson, Mary, L. Pharmaceutical compositions containing an omega-3 fatty acid oil
ID25908A (id) * 1998-03-06 2000-11-09 Novartis Ag Prakonsentrat-prakonsentrat emulsi yang mengandung siklosporin atau makrolida
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
EP0982035B1 (en) * 1998-08-18 2004-03-31 Panacea Biotec Limited Cyclosporin composition comprising an hydrophilic carrier
US6638522B1 (en) * 1998-12-11 2003-10-28 Pharmasolutions, Inc. Microemulsion concentrate composition of cyclosporin
ATE404172T1 (de) 1998-12-30 2008-08-15 Dexcel Ltd Dispergierbares konzentrat zur verabreichung von cyclosporin
GB9903547D0 (en) 1999-02-16 1999-04-07 Novartis Ag Organic compounds
CN1167462C (zh) * 1999-03-09 2004-09-22 杭州华东医药集团生物工程研究所有限公司 一种含环孢素的药物组合物
US6956048B2 (en) 1999-03-31 2005-10-18 Pharmacia & Upjohn Company Pharmaceutical emulsions for retroviral protease inhibitors
WO2001032143A1 (en) * 1999-11-02 2001-05-10 Cipla Ltd. A pharmaceutical composition for the administration of water-insoluble pharmaceutically active substances and a process for preparation thereof
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
GB0008785D0 (en) 2000-04-10 2000-05-31 Novartis Ag Organic compounds
GB0019118D0 (en) * 2000-08-03 2000-09-27 Danisco Solid phase glycerolysis
CN100421565C (zh) * 2000-08-08 2008-10-01 花王株式会社 油/脂组合物
US7115565B2 (en) 2001-01-18 2006-10-03 Pharmacia & Upjohn Company Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
AR033711A1 (es) * 2001-05-09 2004-01-07 Novartis Ag Composiciones farmaceuticas
IL160761A0 (en) 2001-10-19 2004-08-31 Isotechnika Inc Novel cyclosporin analog microemulsion preconcentrates
MXPA04003625A (es) 2001-10-19 2004-12-02 Sotechnika Inc Sintesis de analogos de ciclosporina.
KR100441167B1 (ko) * 2001-12-27 2004-07-21 씨제이 주식회사 마이크로에멀젼 예비 농축액 조성물
KR100525234B1 (ko) * 2003-02-19 2005-10-28 한국유나이티드제약 주식회사 사이클로스포린 함유 연질캅셀제 및 그 제조방법
GT200500310A (es) * 2004-11-19 2006-06-19 Compuestos organicos
GB0504950D0 (en) 2005-03-10 2005-04-20 Novartis Ag Organic compositions
JP4889262B2 (ja) * 2005-08-19 2012-03-07 理研ビタミン株式会社 脂溶性薬剤組成物
MD3347G2 (ro) * 2006-12-26 2008-01-31 Институт Сельскохозяйственной Техники "Mecagro" Procedeu de obţinere a esterilor metilici din ulei de rapiţă
ITPD20070049A1 (it) * 2007-02-14 2008-08-15 Sila S R L Prodotto a base di acido linoleico coniugato e processo per la sua fabbricazione
ES2393814T3 (es) 2007-04-04 2012-12-28 Sigmoid Pharma Limited Una composición farmacéutica oral
CN101199836B (zh) * 2007-11-07 2011-03-30 安徽省药物研究所 一种阶段释放型环孢素a固体微乳制剂及其微乳固化方法
ES2530049T3 (es) 2009-05-18 2015-02-26 Sigmoid Pharma Limited Composición que comprende gotas de aceite
CN102573802A (zh) 2009-08-12 2012-07-11 希格默伊德药业有限公司 包含聚合物基质和油相的免疫调节组合物
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
JO3337B1 (ar) 2010-12-13 2019-03-13 Debiopharm Sa تركيبات صيدلية تشمل أليسبوريفير
FR2971941B1 (fr) 2011-02-24 2013-08-02 Physica Pharma Compositions pharmaceutiques administrables par voie cutanee et destinees au traitement local de la dermatite atopique canine
GB201304662D0 (en) 2013-03-14 2013-05-01 Sigmoid Pharma Ltd Compositions
JP6716582B2 (ja) 2014-11-07 2020-07-01 サブリミティ・セラピューティクス・リミテッドＳｕｂｌｉｍｉｔｙ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｌｉｍｉｔｅｄ シクロスポリンを含む組成物
WO2020050182A1 (ja) * 2018-09-06 2020-03-12 株式会社カマタ カプセル充填用液状組成物及びカプセル剤
FI3886813T3 (fi) * 2018-11-26 2023-05-04 Hepion Pharmaceuticals Inc Syklosporiinianalogien farmaseuttisia formulaatioita

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1274354A (fr) * 1956-03-10 1961-10-27 Agents tensio-actifs obtenus à partir de triglycérides et polyéthylène glycol
FR2344283A1 (fr) * 1976-03-17 1977-10-14 Gattefosse Ets Sa Nouveau melange de glycerides utile comme nutriment lipidique
DE2907460A1 (de) * 1978-03-07 1979-09-13 Sandoz Ag Neue resorbierbare galenische kompositionen
CH641356A5 (en) * 1979-02-27 1984-02-29 Sandoz Ag Pharmaceutical compositions containing cyclosporin
BE895724A (fr) * 1982-02-01 1983-07-28 Sandoz Sa Nouvelle utilisation therapeutique de la dihydrocyclosporine d
GB8903804D0 (en) * 1989-02-20 1989-04-05 Sandoz Ltd Improvements in or relating to organic compounds
DE3444893A1 (de) * 1984-12-08 1986-06-12 Henkel KGaA, 4000 Düsseldorf Verfahren zur herstellung von fettsaeuremethylestern
JPS62201591A (ja) * 1986-02-28 1987-09-05 Shoichi Shimizu 油脂のグリセロリシス法
JP2632010B2 (ja) * 1988-01-29 1997-07-16 三共株式会社 シクロスポリン製剤
CH679119A5 (pt) * 1988-05-13 1991-12-31 Sandoz Ag
HU201567B (en) * 1988-07-21 1990-11-28 Gyogyszerkutato Intezet Process for production of intravenous medical compositions containing cyclosphorin
KR0148748B1 (ko) * 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
GB8823621D0 (en) * 1988-10-07 1988-11-16 Madhok R Compositions containing cyclosporins
JPH0738771B2 (ja) * 1989-01-17 1995-05-01 花王株式会社 液状食用油組成物
CH679277A5 (pt) * 1989-02-09 1992-01-31 Sandoz Ag
AU6785490A (en) * 1989-12-18 1991-06-20 Kraft General Foods, Inc. Low-saturate edible oils and transesterification methods for production thereof
GB9113872D0 (en) * 1991-06-27 1991-08-14 Sandoz Ag Improvements in or relating to organic compounds

Also Published As

Publication number Publication date
EP0953630B1 (en) 2004-09-08
KR930000113A (ko) 1993-01-15
EE03108B1 (et) 1998-08-17
JPH05186365A (ja) 1993-07-27
AT403436B (de) 1998-02-25
TW267943B (pt) 1996-01-11
PT539319E (pt) 2000-05-31
KR100231385B1 (en) 1999-11-15
PH30337A (en) 1997-04-02
NO325267B1 (no) 2008-03-17
FI961513A0 (fi) 1996-04-03
EP0539319B1 (en) 1999-12-08
CA2072509C (en) 1996-07-30
ES2227921T3 (es) 2005-04-01
FI922958A0 (fi) 1992-06-25
DE4244986B4 (de) 2008-07-24
HK57196A (en) 1996-04-12
ATA129892A (de) 1997-07-15
GB9113872D0 (en) 1991-08-14
CA2175842C (en) 2002-05-07
CY1906A (en) 1992-06-24
GB2257359A (en) 1993-01-13
GB9213393D0 (en) 1992-08-05
FR2685706B1 (pt) 1994-12-23
FI116199B (fi) 2005-10-14
DK0953630T3 (da) 2004-11-01
AU1852792A (en) 1993-03-11
RO111021B1 (ro) 1996-06-28
NO964382D0 (no) 1996-10-15
HU9201975D0 (en) 1992-09-28
DK0539319T3 (da) 2000-05-22
CA2072509A1 (en) 1992-12-28
NO922506D0 (no) 1992-06-25
DE4244930C2 (de) 1999-11-11
MX9203236A (es) 1992-12-01
SA92130213B1 (ar) 2004-07-24
FR2685706A1 (fr) 1993-07-02
CN1077798C (zh) 2002-01-16
EP0953630A1 (en) 1999-11-03
LU88138A1 (fr) 1994-03-01
CZ197792A3 (en) 1993-01-13
RU2143919C1 (ru) 2000-01-10
CN1079907A (zh) 1993-12-29
IL118546A0 (en) 1996-10-16
JP2653958B2 (ja) 1997-09-17
EP0539319A3 (en) 1993-06-09
NZ243309A (en) 1995-02-24
FI922958L (fi) 1992-12-28
GB2257359B (en) 1996-01-10
JP3420897B2 (ja) 2003-06-30
IL118546A (en) 1998-09-24
HUT62201A (en) 1993-04-28
FR2678169B1 (fr) 1994-08-26
AU659460B2 (en) 1995-05-18
FI961513L (fi) 1996-04-03
IT1254401B (it) 1995-09-14
DE4219526A1 (de) 1993-03-18
SK278759B6 (sk) 1998-02-04
SK197792A3 (en) 1994-03-09
CH684163A5 (de) 1994-07-29
JPH09118894A (ja) 1997-05-06
NO964382L (no) 1992-12-28
HK157696A (en) 1996-08-30
ITRM920476A1 (it) 1993-12-23
NO303964B1 (no) 1998-10-05
GR3032366T3 (en) 2000-04-27
IL102310A (en) 1997-03-18
KR100231384B1 (en) 1999-11-15
EP0539319A2 (en) 1993-04-28
IL102310A0 (en) 1993-01-14
NO922506L (no) 1992-12-28
FI109454B (fi) 2002-08-15
HU216792B (hu) 1999-08-30
ES2142818T3 (es) 2000-05-01
IE73662B1 (en) 1997-06-18
DE4219526C2 (de) 1999-04-22
MY109512A (en) 1997-02-28
UA35559C2 (uk) 2001-04-16
RO111110B1 (ro) 1996-06-28
KR0131064B1 (ko) 1998-04-17
CZ281790B6 (cs) 1997-01-15
CA2175842A1 (en) 1992-12-28
IE922082A1 (en) 1992-12-30
ITRM920476A0 (it) 1992-06-23
CH685764A5 (de) 1995-09-29
ZA924719B (en) 1993-12-27
FR2678169A1 (fr) 1992-12-31
UY23864A1 (es) 1995-05-29

Similar Documents

Publication Publication Date Title
PT953630E (pt) Produtos de trans-esterificacao de oleo de milho e glicerol e seu uso em composicoes farmaceuticas
MX9202778A (es) Sistema de envasado y composicion adecuada para ser envasada en dicho sistema.
PT100779A (pt) Acidos amidazolil-alcenoico, composicoes farmaceuticas que os contem e seu uso
BR9302393A (pt) Composicoes de fibra dietetica para uso em alimentos
BR9306247A (pt) Composiçoes alimentícias derivadas de vitamina d e métodos de uso
NO931524L (no) Absorberende gjenstand med bestanddeler som kan skilles fra hverandre under bruk
FI945838A7 (fi) Ektoiini ja ektoiinijohdannaiset kosteuttavina aineina kosmetiikkatuotteissa
BR9408331A (pt) Composição e artigo lavável
UY24370A1 (es) Nuevos taxoides,eterificados en posición 7 y 10, su preparación y composiciones farmacéuticas parenterales que los contienen
FI901554A7 (fi) Biosidikoostumus ja sen käyttö
BR9100405A (pt) Composicao oleaginosa e composicao concentrada de aditivo de oleo
FI893845L (fi) Puunkyllästysaine ja sen käyttö
FI942932A7 (fi) Farmaseuttinen koostumus ja menetelmä sen valmistamiseksi
MX9101341A (es) Derivados de 2-aminopiridina-4-carboxamida,su preparacion y su aplicacion en terapeutica
IT1217121B (it) Eteri di poligliceroli e loro impiego in composizioni cosmetiche e farmaceutiche
FI910728A7 (fi) Leukotrieeni-antagonisteja koskevia ja niihin liittyviä parannuksia
MX9100952A (es) Composiciones de tereftalato de polietileno y metodos para su uso
BR8905444A (pt) Composicoes e aplicacao
FR2626155B1 (fr) Fauteuil multifonction et multiposition
MX9205556A (es) Mejoras en composiciones novedosas que comprenden pentafluoroetano y monoclorodifluorometano.
MX9204917A (es) Sustancias y composiciones con actividad antineoplastica y procedimiento para su obtencion.
FI893834A7 (fi) Koostumus ja sen käyttö
FI920354A7 (fi) Riboflaviinikoostumus ja menetelmä sen valmistamiseksi
IT1076973B (it) Mobilio ed elementi strutturali per l'uso in tale mobilio
BR8907523A (pt) Composicoes de revestimentos e polianidridos para uso nas mesmas